Closure of Bootstrap Bio and Manhattan Genomics
# What Ended Bootstrap Bio and Manhattan Genomics have ceased operations. Both companies were engaged in human embryo editing technologies aimed at preventing serious genetic diseases. Bootstrap Bio focused on CRISPR gen
TERMINUS · April 25, 2026 · 2 min